Chemicals

Survodutide

<p><div><span style="mso-spacerun:&#39;yes&#39;;font-size:12pt;font-family:&#39;TimesNewRomanPS-BoldMT&#39;;color:rgb(0,0,0);font-weight:bold;">Survodutide 5MG</span></div><div><span style="mso-spacerun:&#39;yes&#39;;font-size:12pt;font-family:&#39;TimesNewRomanPS-BoldMT&#39;;color:rgb(0,0,0);font-weight:bold;">Survodutide 10MG</span></div><br/></p>

SupplierFuBai Peptidewww.glpfactory.com
Source categories

About this product

Product information from the supplier.

Survodutide is an investigational, once-weekly injectable drug developed by Boehringer Ingelheim and Zealand Pharma. As a dual agonist that simultaneously targets both GLP-1 and glucagon receptors, it not only reduces appetite but also boosts the body's energy expenditure and directly breaks down liver fat.